Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
injectable, inhalation, and intranasal products, has reported an insider sale according to a recent SEC filing. Director Michael Zasloff sold 12,500 shares of the company on March 5, 2024.The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission, which can be accessed through this SEC Filing . Following this transaction, the insider's total sales over the past year amount to 32,759 shares, with no recorded purchases in the same period. The insider transaction history for Amphastar Pharmaceuticals Inc shows a pattern of insider sales, with 34 recorded over the past year and no insider buys in the same timeframe.On the valuation front, Amphastar Pharmaceuticals Inc shares were trading at $47.18 on the day of the insider's recent sale, giving the company a market cap of $2.225 billion. The price-earnings ratio stands at 17.95, which is below the industry median of 22.74 and also below the company's historical median price-earnings ratio. Considering
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024Accesswire
- Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth [Yahoo! Finance]Yahoo! Finance
- Pharvaris appoints David Nassif as chief financial officer [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/28/24 - Beat
AMPH
Sec Filings
- 5/1/24 - Form 144
- 4/19/24 - Form DEFA14A
- 4/12/24 - Form ARS
- AMPH's page on the SEC website